Evaluation of an ACT and PBS Group for Parents and Education Staff
Launched by UNIVERSITY OF EDINBURGH · Apr 12, 2019
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
Study Design
The study has a mixed methods design. The mixed methods approach allows the utilisation both quantitative and qualitative approaches to gain a greater level of detail than either one methodology would allow for individually, and for the results to support a firmer conclusion if the differing methodologies corroborate each other.
Protocol
The Learning Disability Child and Adolescent Mental Health Service (LD-CAMHS) service in NHS Lothian (National Health Service board located in Scotland) and schools for children with special educational needs in the City of Edinburgh Council...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parent or Guardian of a Child aged 5-18 with a diagnosis of an Intellectual Disability/Learning Disability and experience of challenging behaviour.
- • OR an employee working in a school for children with additional support needs, directly working with children with diagnosed Intellectual/Learning Disabilities.
- • Must speak English fluently.
- • Must be able to provide informed consent.
- Exclusion Criteria:
- • Temporary staff members (contract remaining of less than six months).
- • Parents or Education Staff aged less than 18 years old.
- • Parents or Education staff that have a diagnosis of an ID, such that they would not be able to understand the group materials or questionnaires and complete them independently.
- • Individuals who are not able to provide informed consent.
Trial Officials
Corinne Reid, MPsych, PhD
Principal Investigator
University of Edinburgh
About University Of Edinburgh
The University of Edinburgh, a prestigious institution renowned for its commitment to research excellence and innovation, serves as a leading clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a strong emphasis on multidisciplinary collaboration, the university facilitates cutting-edge clinical studies that aim to explore novel therapies and improve patient outcomes. Leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, the University of Edinburgh is at the forefront of translating scientific discoveries into practical applications, thereby contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edinburgh, Midlothian, United Kingdom
Edinburgh, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials